RB1 and small cell lung carcinoma: Under EGFR-TKI pressure, however, those same pluripotent cells may have accumulated additional genetic alterations (such as loss of RB1 and TP53) and maintained a different epigenetic state to differentiate into an EGFR-independent lineage (such as SCLC).